Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Assets: 2010-2024

Historic Return on Assets for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -0.30%.

  • China Pharma Holdings' Return on Assets rose 13.00% to -0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.22%, marking a year-over-year increase of 13.00%. This contributed to the annual value of -0.30% for FY2024, which is 12.00% down from last year.
  • Per China Pharma Holdings' latest filing, its Return on Assets stood at -0.30% for FY2024, which was down 68.05% from -0.18% recorded in FY2023.
  • China Pharma Holdings' Return on Assets' 5-year high stood at -0.13% during FY2020, with a 5-year trough of -0.30% in FY2024.
  • Its 3-year average for Return on Assets is -0.23%, with a median of -0.20% in 2022.
  • As far as peak fluctuations go, China Pharma Holdings' Return on Assets soared by 48bps in 2020, and later decreased by 12bps in 2024.
  • China Pharma Holdings' Return on Assets (Yearly) stood at -0.13% in 2020, then declined by 2bps to -0.16% in 2021, then dropped by 4bps to -0.20% in 2022, then grew by 2bps to -0.18% in 2023, then dropped by 12bps to -0.30% in 2024.